Sharenet Sites 
Sharenet Sites
Labat Exports 26% THC Medicinal Grade Cannabis as it ramps up delivery from its SAHPRA Approved Cultivation Ops....
LABAT AFRICA LIMITED
Incorporated in the Republic of South Africa
(Registration number 1986/001616/06)
JSE code: LAB ISIN: ZAE000018354
(“Labat” or “the Company” or “the Group”)
FSE Code: LEI 9845000R73DF5EE41J88
LABAT EXPORTS 26% THC MEDICINAL GRADE CANNABIS AS IT RAMPS UP DELIVERY FROM ITS SAHPRA
APPROVED CULTIVATION OPERATION IN KENTON-ON-SEA TO THE AUSTRALIAN AND EUROPEAN MARKETS
Shareholders are advised that Labat has made excellent progress with regard to the upgrade of its
SAHPRA approved medicinal cannabis cultivation facility in Kenton-on-Sea, (known as Sweetwaters)
which is already showing excellent results in return.
Performance of Cultivation Facility
As previously announced, Labat has secured an offtake agreement with buyers in Europe,
particularly Switzerland and Germany as well as Australia, for the supply of cannabis products. Since
the dual listing of Labat in Frankfurt in December 2021, Labat has regularly been approached by
brokers and international buyers of cannabis flower, for the supply of medicinal grade THC flower
from South Africa.
Since Labat’s operational takeover of Sweetwaters on 1 March 2022, Labat has made several key
staff appointments, as well as assessing and improving its operating procedures and cultivation
techniques. Since the upgrades to the cultivation facilities under the leadership of a specialist team,
the Company is pleased to announce its first harvest of 1.2 tons in wet weight product with a yield of
100kg in dry weight. The Eastern Cape based operation is supported by a team of highly skilled
breeders, growers and researchers.
Sweetwaters has an offtake agreement in place with an Australian pharmaceutical client and Labat
has now facilitated the export of the current yield to the Queensland based buyer.
Labat will use its funding lines and in-house expertise to make significant capital investments to
upgrade the existing infrastructure in order to increase the production capacity from 500kg to 1.8
tons per year, in dry weight. The capital investment will also be used to set up a European Union
Good Manufacturing Processes (EU-GMP) processing facility at the site, with the assistance of a
German Pharmaceutical company.
Certificate of Analysis & THC levels achieved
As per the standard Sweetwater operating procedure, and in compliance to the SAHPRA
conventions for a licensed cultivation facility, Labat wishes to inform all shareholders that the THC
potency of the current Sweetwater harvest is in excess of 26% as per the verified results of National
Analytical Forensic Services (NAFS), *TM006.3 Test Method (Potency Cannabis HPLC). NAFS is a
SAHPRA accredited testing facility.
Johannesburg
26 May 2022
Sponsor
AcaciaCap Advisors Proprietary Limited
Date: 26-05-2022 08:50:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
